This measure is used to assess the percentage of acute ischemic stroke patients 18 years of age and older who arrive at the hospital within 120 minutes (2 hours) of time last known well and for whom intravenous recombinant tissue plasminogen activator (IV r-TPA or t-PA) was initiated at this hospital within 180 minutes (3 hours) of time last known well.
Before You View Your Report...
By agreeing to the terms of use for WhyNotTheBest.org, you acknowledge that the material on the site is for informational use only, and is not intended to be relied upon for medical diagnoses, treatment or advice on selecting providers.
Further, you explicitly acknowledge that IPRO is not an accreditor or evaluator of health care organizations or systems, and that a reference to an institution on the Web site is not an endorsement by IPRO for the receipt of health care from the institution. You agree that IPRO's name and/or logo will not be used by health care organizations or other entities as an endorsement of performance or in any advertisement or marketing of health care services.
We encourage the use of the performance data and other information for informational and educational purposes. We request that you explicitly cite the source of the data and/or information as such:
WhyNotTheBest.org, [Date Accessed] based on data from [Time Frame]
If you would like to use elements of the Web site design, such as the banner, logo, or tag line, please request permission—including an example of the intended use—by sending an e-mail to
wntb-support@ipro.us.
This message will not appear again during the session.
